Paper22305802
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
Sperling R and 19 others. Lancet Neurol, 2012. Cited by 426 papers, by iCite.
Cite this record
ConductScience Library. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Papers, record 22305802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22305802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Amyloid beta-Peptides | Major topic |
| Antibodies, Monoclonal, Humanized | Major topic |
| Brain | Major topic |
| Neuroimaging | Major topic |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Magnetic Resonance Imaging | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Risk Factors |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| G1100810 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| P30 AG062421 | NIA NIH HHS | United States | P30AG062421 | PubMed | NIH RePORTER |
| P50 AG005134 | NIA NIH HHS | United States | P50AG005134 | PubMed and NIH | NIH RePORTER |
| G0601846 | Medical Research Council | United Kingdom | PubMed | PubMed | |
| K24 AG035007 | NIA NIH HHS | United States | K24AG035007 | PubMed and NIH | NIH RePORTER |
| MC_U120036861 | Medical Research Council | United Kingdom | PubMed | PubMed |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 22341028 | ARIA from off-key operas? | https://conductscience.org/library/papers/22341028 |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14755729 | Clinical manifestations of cerebral amyloid angiopathy-related inflammation. | Ann Neurol | 2004 | https://conductscience.org/library/papers/14755729 | PubMed |
| 2 | 20548041 | Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population. | Neurology | 2010 | https://conductscience.org/library/papers/20548041 | PubMed |
| 3 | 18596154 | Immunotherapy reduces vascular amyloid-beta in PDAPP mice. | J Neurosci | 2008 | https://conductscience.org/library/papers/18596154 | PubMed |
| 4 | 18755411 | Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. | J Stroke Cerebrovasc Dis | 2008 | https://conductscience.org/library/papers/18755411 | PubMed |
| 5 | 18378884 | Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. | Neurology | 2008 | https://conductscience.org/library/papers/18378884 | PubMed |
| 6 | 7654074 | Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. | Ann Neurol | 1995 | https://conductscience.org/library/papers/7654074 | PubMed |
| 7 | 21307170 | Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. | Stroke | 2011 | https://conductscience.org/library/papers/21307170 | PubMed |
| 8 | 21784350 | Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab. | Alzheimers Dement | 2011 | https://conductscience.org/library/papers/21784350 | PubMed |
| 9 | 20505438 | A single ascending dose study of bapineuzumab in patients with Alzheimer disease. | Alzheimer Dis Assoc Disord | 2010 | https://conductscience.org/library/papers/20505438 | PubMed |
| 10 | 20153809 | Amyloid load in nondemented brains correlates with APOE e4. | Neurosci Lett | 2010 | https://conductscience.org/library/papers/20153809 | PubMed |
| 11 | 18953056 | Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. | Brain | 2008 | https://conductscience.org/library/papers/18953056 | PubMed |
| 12 | 17452586 | Course of cerebral amyloid angiopathy-related inflammation. | Neurology | 2007 | https://conductscience.org/library/papers/17452586 | PubMed |
| 13 | 14872042 | Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. | Neurology | 2004 | https://conductscience.org/library/papers/14872042 | PubMed |
| 14 | 12787320 | APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. | Neuropathol Appl Neurobiol | 2003 | https://conductscience.org/library/papers/12787320 | PubMed |
| 15 | 21784348 | Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. | Alzheimers Dement | 2011 | https://conductscience.org/library/papers/21784348 | PubMed |
| 16 | 19762705 | Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. | Stroke | 2009 | https://conductscience.org/library/papers/19762705 | PubMed |
| 17 | 18363936 | Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. | Brain Pathol | 2008 | https://conductscience.org/library/papers/18363936 | PubMed |
| 18 | 21987394 | Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. | Arch Neurol | 2012 | https://conductscience.org/library/papers/21987394 | PubMed |
| 19 | 11387493 | A new rating scale for age-related white matter changes applicable to MRI and CT. | Stroke | 2001 | https://conductscience.org/library/papers/11387493 | PubMed |
| 20 | 21263194 | Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient. | J Alzheimers Dis | 2011 | https://conductscience.org/library/papers/21263194 | PubMed |
Cited by277
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 426 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42934592 | Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report. | BMC Neurol | 2026 | https://conductscience.org/library/papers/42934592 | PubMed |
| 42908770 | Topography and risk factors of amyloid-related imaging abnormality: real-world data from 168 aducanumab-treated patients at a private clinic in South Korea. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42908770 | PubMed |
| 42825842 | Incidence, severity, and associated risk factors for amyloid-related imaging abnormalities in anti-amyloid monoclonal antibody therapy for early Alzheimer's disease: a systematic review and meta-analysis. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42825842 | PubMed |
| 42779634 | Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy. | bioRxiv | 2026 | https://conductscience.org/library/papers/42779634 | PubMed |
| 42766053 | T1 mapping in Alzheimer's disease: a quantitative MRI study with amyloid-PET correlation. | Eur Radiol Exp | 2026 | https://conductscience.org/library/papers/42766053 | PubMed |
| 42605139 | Gantenerumab for Early Alzheimer's Disease: An Updated Systematic Review and Meta-Analysis. | Brain Behav | 2026 | https://conductscience.org/library/papers/42605139 | PubMed |
| 42459526 | APOE ε4-associated hippocampal atrophy trajectories across the Alzheimer's disease continuum: a systematic review, meta-analysis, and longitudinal validation. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42459526 | PubMed |
| 42440762 | Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42440762 | PubMed |
| 42363270 | Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42363270 | PubMed |
| 42301522 | Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42301522 | PubMed |
| 42169086 | Plasma ApoE proteotyping for ApoE ε4 stratification in the anti-amyloid therapies era. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42169086 | PubMed |
| 42040755 | MRI evaluation of cerebral perivascular spaces predicts amyloid-related imaging abnormalities risk in preclinical Alzheimer's disease. | Front Dement | 2026 | https://conductscience.org/library/papers/42040755 | PubMed |
| 42039150 | Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer's disease therapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42039150 | PubMed |
| 42015334 | Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42015334 | PubMed |
| 41946975 | The potential of low-field MRI for global dementia care. | Nat Rev Neurol | 2026 | https://conductscience.org/library/papers/41946975 | PubMed |
| 41867862 | Early Binding of Anti-Amyloid Antibodies to CAA Drives Complement Activation, Inflammation and ARIA in Mice. | bioRxiv | 2026 | https://conductscience.org/library/papers/41867862 | PubMed |
| 41803942 | In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/41803942 | PubMed |
| 41724678 | Spatially resolved transcriptomic profiling identifies distinct signatures in parenchymal and vascular microenvironments in Alzheimer's Disease with Cerebral Amyloid Angiopathy. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41724678 | PubMed |
| 41571449 | Amyloid-related imaging abnormalities (ARIA) in Alzheimer's immunotherapy: a framework and challenges for global surveillance strategies. | J Neurol Neurosurg Psychiatry | 2026 | https://conductscience.org/library/papers/41571449 | PubMed |
| 41409668 | APOE ε 4 -Associated Hippocampal Atrophy Trajectories Across the Alzheimer's Disease Continuum: A Systematic Review, Meta-Analysis, and Longitudinal Validation. | medRxiv | 2025 | https://conductscience.org/library/papers/41409668 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| GK | 2710 | PubTator's text mining | https://conductscience.org/library/genes/2710 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22305802
GET https://conductscience.org/api/papers/v1/22305802/references?page=2